The automated and closed cell therapy processing systems market is valued at USD 1.74 billion in 2025 and is projected to reach USD 8.86 billion by 2034, at a CAGR of 19.84%.Ottawa, Sept. 18, 2025 ...

Celltrio®, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell & gene therapy, today announced the closing of a $15 million financial investment ...

To start off, could you introduce yourselves and Unicorn Biotechnologies? Jack: I’m Jack, one of the co-founders of Unicorn Biotechnologies. My background is in chemistry, and I’ve worked across ...

The technology is designed to improve patient accessibility to cell therapies by improving manufacturing efficiency.

Built-In Cellular for Secure, Always-On Automation MachineMotion AI is the first Vention controller to feature built-in cellular connectivity, enabled through a collaboration with Bell, Canada's ...

MONTREAL, May 5, 2025 /PRNewswire/ - Vention, creator of the world's only full-stack software and hardware automation platform, today announced the commercial availability of its powerful ...

"MachineMotion AI is truly a breakthrough automation control system," said Etienne Lacroix, Founder and CEO at Vention. "With built-in AI computing and independent cellular connectivity, manufacturers ...